Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.

Voruz, Sophie; de Leval, Laurence; Cairoli, Anne

Voruz, Sophie; de Leval, Laurence; Cairoli, Anne.

Affiliation

Voruz S; Service and Central Laboratory of Hematology, University Hospital Lausanne (CHUV), Rue du Bugnon 46, CH - 1011, Lausanne, Switzerland.
de Leval L; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
Cairoli A; Service and Central Laboratory of Hematology, University Hospital Lausanne (CHUV), Rue du Bugnon 46, CH - 1011, Lausanne, Switzerland. anne.cairoli@chuv.ch.

Exp Hematol Oncol ; 10(1): 32, 2021 May 13.

Article de En | MEDLINE | ID: mdl-33985594

Mots clés

Cutaneous T-cell lymphoma; Primary cutaneous gamma-delta T-cell lymphoma; Refractory disease; Targeted treatment

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies Langue: En Journal: Exp Hematol Oncol Année: 2021 Type de document: Article Pays d'affiliation: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google